Cite
HARVARD Citation
He, C. et al. (2022). A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus. MedComm. 2 (3), pp. 430-441. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, C. et al. (2022). A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus. MedComm. 2 (3), pp. 430-441. [Online].